Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Hospitals, advocacy groups clash over bill to bar manufacturer limits on 340B contract pharmacies
Summary
House Bill 2385 A would forbid drug manufacturers from restricting a pharmacy’s ability to acquire or dispense 340B drugs for covered entities. Hospitals and safety‑net advocates said the bill would restore prior practice and protect community access; bioscience and industry groups warned of risks to investment and oversight.
The Senate Committee on Healthcare on May 8 reopened public testimony on House Bill 2385 A, which would make it an unlawful trade practice for drug manufacturers to take actions that restrict or interfere with a pharmacy’s ability to acquire or dispense 340B drugs when the pharmacy has a contract with a covered entity such as a federally qualified health center or safety‑net hospital.
Supporters — including hospital representatives and safety‑net advocacy groups — argued manufacturers’ recent restrictions on contract pharmacies have diverted 340B…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
